Exosome application has emerged as a promising nanotechnology discipline for various
diseases therapeutics and diagnoses. Owing to the natural properties of efficient drug …

Brain diseases, such as brain tumors, neurodegenerative diseases, cerebrovascular
diseases, and brain injuries, are caused by various pathophysiological changes, which pose …

Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of
origin and change the functions and phenotypes of other cells. These features indicate …

Diseases of the central nervous system (CNS) are challenging to treat, mainly due to the
blood-brain barrier (BBB), which restricts drugs in circulation from entering target regions in …

This review focusses on the significance of fluorescent, phosphorescent labelling and
tracking of extracellular vesicles (EVs) for unravelling their biology, pathophysiology, and …

Aims: Blood biomarkers can improve drug development for Alzheimer's disease (AD) and its
treatment. Neuron-derived extracellular vesicles (NDEVs) in plasma offer a minimally …

Cell membrane-based biovesicles (BVs) are important candidate drug delivery vehicles and
comprise extracellular vesicles, virus-like particles, and lentiviral vectors. Here, we introduce …

Aging is linked to the deterioration of many physical and cognitive abilities and is the leading
risk factor for Alzheimer's disease. The growing aging population is a significant healthcare …

Background: Human cell-secreted extracellular vesicles (EVs) are versatile nanomaterials
suitable for disease-targeted drug delivery and therapy. Native EVs, however, usually do not …

In the central nervous system (CNS), the crosstalk between neural cells is mediated by
extracellular mechanisms, including brain-derived extracellular vesicles (bdEVs). To study …